Advertisement
Home »

Lessons from SENCOVAC: A prospective study evaluating the response to SARS-CoV-2 vaccination in the CKD spectrum.

May 08, 2023

REFERENCES & ADDITIONAL READING

PubMed

ABOUT THE CONTRIBUTORS

  • Borja Quiroga

    IIS-La Princesa, Nephrology Department, Hospital Universitario de la Princesa, Madrid, Spain.

    María José Soler

    Nephrology Department, Vall d’Hebrón University Hospital, Barcelona, Spain; RICORS2040 (Kidney Disease), Spain. Electronic address: mjsoler01@gmail.com.

    Alberto Ortiz

    RICORS2040 (Kidney Disease), Spain; IIS-Fundación Jiménez Diaz, School of Medicine, Universidad Autónoma de Madrid, Fundación Renal Iñigo Álvarez de Toledo-IRSIN, REDinREN, Instituto de Investigación Carlos III, Madrid, Spain. Electronic address: aortiz@fjd.es.

    Patricia de Sequera

    RICORS2040 (Kidney Disease), Spain; Nephrology Department, Hospital Universitario Infanta Leonor – Universidad Complutense de Madrid, Spain.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement